Navigation Links
Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director
Date:1/11/2012

f cancer by successfully driving its pipeline of antibody-based therapeutics into the clinic."

Dr Christian Rohlff, CEO of OBT, commented, "I am delighted to welcome Glenn to OBT.  His wealth of relevant clinical and commercial expertise in the oncology and antibody field will be instrumental in helping OBT to transition into a successful clinical development organisation as the company works to enhance the future treatment prospects for cancer patients with no treatment."

Today's announcement follows OBT's recent collaboration with Seattle Genetics, Inc. for the development of antibody drug conjugates (ADCs) for cancer, highlighting OBT's growing recognition in the ADC field.  

About OGAP®

The Oxford Genome Anatomy Project (OGAP®) database represents one of the world's largest proprietary collections of disease-associated proteins. OGAP® oncology contains proteomic data on over 7,500 cancer membrane proteins combined with genomic and clinical information derived from human blood and cancer tissue studies. OGAP® contains proprietary target information on three-quarters of the entire human proteome. Almost two million human protein fragments have been sequenced in OGAP® in 50 different human tissues representing 60 diseases, including 25 forms of cancer. OGAP® integrates data covering 17,000 different genes and over eight million genetic variants (SNPs and haplotypes).

About Oxford BioTherapeutics

Oxford BioTherapeutics (OBT) is a leading international biotechnology company focused on the development and commercialization of innovative antibody-based cancer medicines, with integrated diagnostics, against novel targets that it has discovered in its unique OGAP® proteomic database. OBT accesses leading antibody technologies and expertise through its partnerships with many of the world leaders in antibody development, including BMS (Medarex), Amgen, Alere (formerly Biosite) and BioWa,
'/>"/>

SOURCE Oxford BioTherapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Oxford BioMedica Announces US IND Approval for Novel Ocular Product in Usher Syndrome Type 1B
2. CMC Biologics Licenses Its CHEF1® Expression System to Oxford BioTherapeutics
3. Oxford BioMedica Announces 5T4 Antibody Research Collaboration with ImaginAb
4. Oxford Finance Corporation Sponsors 2010 Mid-Atlantic Bio
5. Oxford Resource Partners, LP and Mendel Biotechnology, Inc. Announce a Miscanthus Biomass Pilot Project in Ohio
6. Oxford Finance Corporation Hires Dr. Killu Sanborn to Support Life Science Business Development in Western North America
7. ALS Therapy Development Institute and Oxford BioMedica Begin Second Phase of Collaboration to Develop Gene Therapies for Amyotrophic Lateral Sclerosis
8. Oxford BioTherapeutics Appoints Michael Moore as Chairman
9. Oxford Performance Materials Introduces OXPEKK PermettaTM High Performance Polymer Films
10. TED Conferences Announces 25 TED Fellows for TEDGlobal in Oxford
11. The Court Supports Bavarian Nordics Decision to Start Patent Infringement Case Against Oxford BioMedica
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 28, 2014 Research and Markets ... Biology Market 2014-2018" report to their offering. ... term synthetic biology covers the designing and engineering of ... as the redesigning of natural biological systems that provide ... a form of extreme genetic engineering because it not ...
(Date:7/28/2014)...   Propeller Health , the FDA-cleared digital health ... Brad Towle as Senior Vice President, Business ... the company,s sales growth, customer acquisition and program expansion. ... his past role in the development of accountable care ... pivotal time in the industry," said David Van ...
(Date:7/28/2014)... COLLEGE STATION, Texas , July 28, 2014   ... will be a 177-key, 4-star boutique hotel in the heart of ... , Texas.  Photo - http://photos.prnewswire.com/prnh/20140725/130455 ... first hotel within ATLAS , The ... of standard rooms and suites, a sleek restaurant and bar, a ...
(Date:7/25/2014)... 25, 2014 Amgen (NASDAQ: AMGN ... a $0.61 per share dividend for the third quarter ... 5, 2014, to all stockholders of record as of ... About Amgen Amgen is committed to unlocking ... illnesses by discovering, developing, manufacturing and delivering innovative human ...
Breaking Biology Technology:Global Synthetic Biology Market 2014-2018 2Propeller Health Hires Brad Towle as Senior Vice President of Business and Client Development 2Texas' Biocorridor Announces the Atlas Hotel, Centerpiece of Mixed Use Community for Biotech Industry 2Texas' Biocorridor Announces the Atlas Hotel, Centerpiece of Mixed Use Community for Biotech Industry 3Texas' Biocorridor Announces the Atlas Hotel, Centerpiece of Mixed Use Community for Biotech Industry 4Amgen Announces 2014 Third Quarter Dividend 2Amgen Announces 2014 Third Quarter Dividend 3
... 12 Eurand N.V.,(Nasdaq: EURX ), a ... products based on its proprietary drug,formulation technologies, announced ... in the NASDAQ Biotechnology Index (Nasdaq: NBI ... Executive Officer of Eurand, commented, "We are,delighted to ...
... Pa., Nov. 9 ,Southern Research Institute and ... expanded their joint marketing agreement to allow ... biotechnology and,pharmaceutical markets. Ten months ago, the ... joint marketing agreement to collaborate in,marketing contract ...
... tests at once with minimal patient discomfort, ... announced today the launch of the ComforTen(TM) Multiple ... device features ten,surgical steel 1.2mm lancet tips, which ... is the only 10-test, self-loading,surgical steel testing device ...
Cached Biology Technology:Eurand Added to NASDAQ Biotechnology Index 2Eurand Added to NASDAQ Biotechnology Index 3Southern Research Expands Sales and Marketing Agreement with Absorption Systems to Service European Market 2HollisterStier Offers Comfort With New ComforTen(TM) Multiple Skin Testing Device 2HollisterStier Offers Comfort With New ComforTen(TM) Multiple Skin Testing Device 3
(Date:7/28/2014)... that have seen an increase in so-called "nuisance flooding"--which ... storm drains and compromised infrastructure--are on the East Coast, ... nuisance flooding, caused by rising sea levels, has increased ... percent since the 1960s. , The report, Sea Level ... States, also finds Annapolis and Baltimore, Maryland, lead the ...
(Date:7/28/2014)... He calls himself the bug hunter, but the target ... be found and identified with special methods and instruments. ... State Veterinary Diagnostic Laboratory at Kansas State University, recently ... enterovirus G, which is an important find in the ... cells, but didn,t know what it was," Hause said. ...
(Date:7/28/2014)... that can help advance the genetic engineering of ... has been developed by researchers with the U.S. ... a multi-institutional partnership led by Lawrence Berkeley National ... an assay that enables scientists to identify and ... components in the biosynthesis of plant cell walls. ...
Breaking Biology News(10 mins):NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 2NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 3Researcher using next-generation sequencing to rapidly identify pathogens 2Researcher using next-generation sequencing to rapidly identify pathogens 3How sweet it is 2How sweet it is 3
... Catch an athlete with clear potential early in his ... years including victory in the Tour de France, and ... about what training and dedication can accomplish. , What ... out about Lance Armstrong was that from 1992-1999, the ...
... vaccines for related viruses including dengue fever. A monoclonal ... Nile virus has an intriguing secret: Contrary to scientists' ... attach to host cells. Instead, the antibody somehow stops ... "This was a complete surprise to us, but it ...
... at the University of Florida's McKnight Brain Institute have ... first time duplicates neurogenesis -- the process of generating ... in today's (June 13) Proceedings of the National Academy ... holds the promise of producing a limitless supply of ...
Cached Biology News:Lance Armstrong through a physiological lens: hard training boosts muscle power 8% 2Lance Armstrong through a physiological lens: hard training boosts muscle power 8% 3Lance Armstrong through a physiological lens: hard training boosts muscle power 8% 4Lance Armstrong through a physiological lens: hard training boosts muscle power 8% 5Lance Armstrong through a physiological lens: hard training boosts muscle power 8% 6Secrets to antibody's success against West Nile Virus surprise scientists 2Secrets to antibody's success against West Nile Virus surprise scientists 3Secrets to antibody's success against West Nile Virus surprise scientists 4For first time, brain cells generated in a dish 2For first time, brain cells generated in a dish 3
Human Ig Lambda-chain, clone ICO-16, Monoclonal Antibody...
Rabbit polyclonal to Warfarin ( Abpromise for all tested applications). Antigen: Chemical / Small Molecule conjugated to KLH...
WNV Core Antibody...
... Rabbit polyclonal to FANCM ( Abpromise ... Antigen: Synthetic peptide derived from within ... FANCM. (Note: the amino acid sequence ... as ab27787 .) ...
Biology Products: